Abrdn Healthcare Investor... (HQH)
NYSE: HQH
· Real-Time Price · USD
19.05
0.15 (0.79%)
At close: Oct 15, 2025, 3:59 PM
19.06
0.05%
After-hours: Oct 15, 2025, 05:36 PM EDT
Abrdn Healthcare Investors Income Statement
Financials in USD. Fiscal
year is
October - September.
Fiscal Year | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
Period Ending | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Revenue | 10.77M | 9.97M | 10.29M | 9.94M | 8.27M | 7.17M | 6.48M | 7.18M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 10.77M | 9.97M | 10.29M | 9.94M | 8.27M | 7.17M | 6.48M | 7.18M |
Operating Income | -220.27K | -1.05M | -1.19M | -1.6M | -3.67M | -5.57M | -6.23M | -4.67M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 184.95M | 72.87M | 56.33M | 3.98M | -194.23M | -48.44M | 155.18M | 281.74M |
Net Income | 184.95M | 72.87M | 56.33M | 3.98M | -194.23M | -48.44M | 155.18M | 281.74M |
Selling & General & Admin | 10.99M | 11.02M | 11.48M | 11.54M | 11.94M | 12.74M | 12.71M | 11.84M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 10.99M | 11.02M | 11.48M | 11.54M | 11.94M | 12.74M | 12.71M | 11.84M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 56.39K | 18.63K | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10.99M | 11.02M | 11.48M | 11.54M | 11.94M | 12.74M | 12.71M | 11.84M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 53.63M | 50.62M | 50.53M | 48.35M | 48.34M | 46.34M | 46.2M | 44.65M |
Shares Outstanding (Diluted) | 53.63M | 50.62M | 50.53M | 48.35M | 48.34M | 46.34M | 46.2M | 44.65M |
EPS (Basic) | 3.56 | 1.44 | 1.19 | 0.08 | -4.12 | -1.04 | 3.42 | 6.31 |
EPS (Diluted) | 3.56 | 1.44 | 1.19 | 0.08 | -4.12 | -1.04 | 3.42 | 6.31 |
EBITDA | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBIT | -220.27K | -1.05M | -1.19M | -1.6M | -3.67M | -5.57M | -6.23M | -4.67M |
Depreciation & Amortization | 220.27K | 1.05M | 1.19M | 1.6M | 3.67M | 5.57M | 6.23M | 4.67M |
Source: Financial Modeling Prep. Financial Sources.